Consumer medicine information

Anapen

Adrenaline (epinephrine)

BRAND INFORMATION

Brand name

Anapen

Active ingredient

Adrenaline (epinephrine)

Schedule

S3

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using Anapen.

SUMMARY CMI

ANAPEN®

Consumer Medicine Information (CMI) summary

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist.

1. Why am I using ANAPEN®?

ANAPEN® contains the active ingredient adrenaline (epinephrine). ANAPEN® is used for the immediate EMERGENCY TREATMENT of a SEVERE ALLERGIC REACTION (also known as ANAPHYLAXIS). For more information, see Section 1. Why am I using ANAPEN®? in the full CMI.

2. What should I know before I use ANAPEN®?

It is important to know how to use an ANAPEN® BEFORE a severe allergic reaction causes a medical emergency. Ask your doctor or pharmacist how you can get an ANAPEN® Training Device for practice.

Do not use if you have ever had an allergic reaction to adrenaline (epinephrine) or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, use any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use ANAPEN®? in the full CMI.

3. What if I am taking other medicines?

Some medicines may interfere with ANAPEN® and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI.

4. How do I use ANAPEN®?

For single use only, please ensure you discard safely immediately after use. Inject into outer part of thigh. If necessary, you can use ANAPEN® through light clothing, such as denim, cotton or polyester. It is important to know how to use your ANAPEN® in an emergency. Read the instructions in the full CMI carefully. Always carry 2 units of auto-injectors in case the first administration fails or if one dose is not sufficient. More instructions can be found in Section 4. How do I use ANAPEN®? in the full CMI.

5. What should I know while using ANAPEN®?

Things you should do

Remind any doctor, dentist or pharmacist you visit that you are using adrenaline (epinephrine)

  • You should always get medical help immediately after using ANAPEN®. Dial 000; ask for an ambulance and state ‘anaphylaxis’ even if symptoms appear to be improving. You will need to go to hospital for observation and further treatment as required. This is because the reaction may happen again at some time later.
  • Check what the expiry date is on your ANAPEN®. Mark this expiry date on your calendar or diary.
  • Replace your ANAPEN® prior to this expiry date.
Things you should not do
  • Do not use ANAPEN® to treat any other complaints unless your doctor tells you to
  • Do not use in children under 15 kg unless advised by your doctor
  • Do not use if: the solution is cloudy, coloured or contains particles, the “injection indicator” is red.
  • Do not inject into hands, feet, ears, nose, buttocks, genital area or into a blood vessel.
Driving or using machinesYou should not drive or use machinery after injecting this medicine, since you may still be experiencing the effects of an anaphylactic shock.
Drinking alcoholAlcohol may adversely affect this medicine by increasing the effects of this medicine.
Looking after your medicine

Keep the auto-injector in the outer carton in order to protect from light.

Store below 25°C

For more information, see Section 5. What should I know while using adrenaline (epinephrine)? in the full CMI.

6. Are there any side effects?

Tell your doctor or pharmacist if you experience a fast or noticeable heartbeat, difficulty breathing, chest pain, shortness of breath. These are some common side effects that may be experienced. For more information, including what to do if you have any side effects, see Section 6. Are there any side effects? in the full CMI.



FULL CMI

ANAPEN®

Active ingredient(s): adrenaline (epinephrine)

ANAPEN® Junior 150 - contains adrenaline (epinephrine) 150 micrograms/0.3mL
ANAPEN® 300 - contains adrenaline (epinephrine) 300 micrograms/0.3mL
ANAPEN® 500 - contains adrenaline (epinephrine) 500 micrograms/0.3mL


Consumer Medicine Information (CMI)

This leaflet provides important information about using ANAPEN®. You should also speak to your doctor or pharmacist if you would like further information or if you have any concerns or questions about using ANAPEN®.

Where to find information in this leaflet:

1. Why am I using ANAPEN®?
2. What should I know before I use ANAPEN®?
3. What if I am taking other medicines?
4. How do I use ANAPEN®?
5. What should I know while using ANAPEN®?
6. Are there any side effects?
7. Product details

1. Why am I using ANAPEN®?

ANAPEN® contains the active ingredient adrenaline (epinephrine). Adrenaline belongs to the group of adrenergic and dopaminergic agents which are classified as cardiac stimulants. It is the medicinal product of choice to provide rapid relief of hypersensitivity reactions to allergies.

Adrenaline is a natural hormone released in response to stress. In acute allergic reactions it improves blood pressure, heart function and breathing, and reduces swelling. Adrenaline is also known as epinephrine.

ANAPEN® is used for the immediate EMERGENCY TREATMENT of a SEVERE ALLERGIC REACTION (also known as ANAPHYLAXIS) caused by peanuts or other foods, medicines, latex, insect bites or stings and other allergens.

ANAPEN® is intended for use in people who have been assessed and advised by their doctor or pharmacist as needing an ANAPEN® to treat their severe allergic reaction.

2. What should I know before I use ANAPEN®?

ANAPEN® is a pre-filled syringe of adrenaline contained in an automatic injection device (Auto-Injector). This injects a single dose of adrenaline into muscle.

Talk to your doctor or pharmacist before using ANAPEN®.

  • Your doctor should have carefully instructed you when to use and the correct way to use your ANAPEN® Auto-Injector.
  • Anyone who has an episode of anaphylaxis should see their doctor about testing for substances they may be allergic to, so these can be strictly avoided in future. It is important to be aware that an allergy to one substance can lead to allergies to a number of related substances.
  • If you have food allergies it is important to check the ingredients in everything you ingest (including medicines) as even small amounts can cause severe reactions
  • Repeated local injection can result in skin damage at sites of injection.
  • Accidental injection into a blood vessel may result in a sudden rise in blood pressure. Accidental injection into the hand or foot may result in loss of blood flow to the affected part. You should immediately seek medical advice.
    Avoidance of known allergens is most important in preventing severe allergic reactions. A severe allergic reaction, otherwise known as anaphylaxis, is overwhelming and life-threatening. It affects the whole body, in particular the
  • heart and blood circulation.
This may cause, for example, low blood pressure and collapse, or abnormal heart beat or function.
  • air passages and lungs.
This causes difficulty in breathing, with noisy wheezing or gasping, possibly with sneezing and a very runny nose.
  • stomach and bowels.
This may cause nausea, vomiting, diarrhoea and abdominal cramps, often severe.
  • skin (very common).
This causes flushing, itching, skin rash, hives or swelling, which may be widespread or in one part of the body.
  • brain.
There may be fits or confusion due to lack of oxygen.

Usually several parts of the body are affected. The patient feels extremely unwell.

It is important to act quickly to treat a severe allergic reaction.

The adrenaline in ANAPEN® treats allergic emergencies. It

  • shrinks abnormally wide blood vessels and
  • makes the heart beat strongly.

This helps improve the very low blood pressure and poor circulation that occur in a severe allergic reaction.

Adrenaline also

  • relaxes the lungs. This eases breathing and lessens wheezing.
  • helps stop
    - swelling, for example, of the face and lips
    - skin rash and/or
    - itching.

Warnings

Do not use ANAPEN® if:

  • you are allergic to adrenaline (epinephrine), or any of the ingredients listed at the end of this leaflet.
  • Always check the ingredients to make sure you can use this medicine.

Give WITH CAUTION to those who have:

  • high blood pressure
  • thyroid problems
  • high pressure in the eye (narrow-angle glaucoma).

Take care also when giving ANAPEN® to those:

  • having an anaesthetic
    or who have:
  • diabetes
  • heart disease
  • allergy to ANAPEN®
  • brain damage.

You should tell your doctor or pharmacist if you have:

  • allergies to any other medicines, foods, preservatives or dye
  • depression, or are on medication for depression
  • thyroid problems, or are on thyroid medication
  • heart disease, including angina or high blood pressure
  • diabetes
  • high pressure in the eye (narrow angle glaucoma)
  • asthma
  • are pregnant or planning to become pregnant
  • ever had an allergic reaction to sodium metabisulfite.
  • lowered potassium levels
  • increased calcium in the blood
  • Disorders of the blood circulation
  • phaeochromocytoma (a type of tumour in the adrenal gland)
  • kidney or prostate disease

During treatment, you may be at risk of developing certain side effects. It is important you understand these risks and how to monitor for them. See additional information under Section 6. Are there any side effects?

Pregnancy and breastfeeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

  • It is not clear whether taking adrenaline during pregnancy is of risk to the unborn child. This should not deter you if you are pregnant from using ANAPEN® in an emergency, as your life might be in danger. You should discuss this with your doctor before such an emergency occurs.
  • Adrenaline is excreted in breast milk

3. What if I am taking other medicines?

Tell your doctor or pharmacist if you are taking any other medicines, including any medicines, vitamins or supplements that you buy without a prescription from your pharmacy, supermarket or health food shop.

Some medicines may interfere with ANAPEN® and affect how it works. These include:

  • Medicines for heart disease, such as digitals (digoxin), beta-blockers, quinidine
  • Medicines for depression, such as tricylic antidepressants, mono amine oxidase inhibitors (MAOIs), serotonin and noradrenaline reuptake inhibitors (SNRIs)
  • Medicines for diabetes, your doctor may change the dosage of your medication after using ANAPEN®
  • Medicines for Parkinson's disease
  • Medicines for thyroid disease
  • Other Medicines: antihistamines such as diphenhydramine or chlorpheniramine, theophylline, ipratropium and oxitropium (used to treat airways disease including asthma), oxytocin (used in labour in pregnancy), inhaled anaesthetics, alpha adrenergic blockers (used to treat high blood pressure), sympathomimetics (used to treat asthma, other airways disease and nasal congestion).

These medicines may be affected by ANAPEN® or may affect how well it works. You may need different amounts of your medicines, or you may need to take different medicines.

Your doctor and pharmacist have more information on medicines to be careful with or avoid while taking this medicine.

Check with your doctor or pharmacist if you are not sure about what medicines, vitamins or supplements you are taking and if these affect ANAPEN®.

4. How do I use ANAPEN®?

When to use ANAPEN®

The reaction usually starts within minutes of contact with the allergen and the person may experience:

  • Itching of the skin, a raised urticarial rash (nettle rash), flushing and swelling of eyes, lips or tongue.
  • Difficulty in breathing due to swelling of the throat. Wheezing, shortness of breath and coughing may result from tightening of the muscles in the lungs.
  • Other symptoms of anaphylaxis including headache, vomiting and diarrhoea.
  • Collapse and loss of consciousness due to a sudden lowering of blood pressure.

When you experience these signs and symptoms use the ANAPEN® Auto-Injector immediately. You must only inject this medicine into the muscle on the outer part of your thigh, not the buttock.

Sometimes a single dose of adrenaline may not be sufficient to completely reverse the effects of a serious allergic reaction. For this reason, your doctor is likely to prescribe more than one ANAPEN®for you. If your symptoms have not improved or have deteriorated within 5-15 minutes after the first injection, either you or the person with you should give a second injection. For this reason you should carry more than one ANAPEN®with you at all times.

In case of a second injection needed it is recommended to inject in the opposite thigh.

How much to use

For single use only, please ensure you discard safely immediately after use. ANAPEN®delivers one single dose of 0.3 mL liquid which is equal to 150/300/500 micrograms adrenaline. After use, a volume of 0.75 mL will remain in the auto-injector but this cannot be reused.

Use in adults

  • The recommended dose is 300 micrograms for individuals under 60 kg bodyweight.
  • For adults over 60 kg, the 300 micrograms dose may not be sufficient and these patients may need ANAPEN®500 micrograms in the autoinjector to reverse the effect of an allergic reaction.
  • Larger adults may require more than one injection to reverse the effect of an allergic reaction.

Use in children: ANAPEN®500 micrograms is not recommended for use in children.

Use in children and adolescents

  • The appropriate dose is 150 micrograms or 300 micrograms.
  • This depends on the body weight of the child and the discretion of the doctor.
  • An Auto-Injector that delivers 150 micrograms of adrenaline is also available. A dosage below 150 micrograms cannot be administered in sufficient accuracy in children weighing less than 15 kg and use is therefore not recommended unless in a life-threatening situation and under medical advice.

Children between 15 kg and 30 kg

The usual dose is 150 micrograms.

Children over 30 kg

The usual dose is 300 micrograms.

How to use ANAPEN®

  • Always use this medicine exactly as your doctor has told you.
  • Check with your doctor or pharmacist if you are not sure.
  • Only inject into the thigh muscle.

Instructions for use

It is recommended that your family members, carers or teachers are also instructed in the correct use of ANAPEN®.

A Parts of the ANAPEN® Auto-injector:

Before you use your ANAPEN® Auto-Injector, you need to know about the parts of the Auto-Injector. These are shown in the picture below – Figure 1

  • Rotating cover over inspection window: You rotate the cover over the solution window to line up the lenses with the solution window on the Auto-Injector body.
  • Inspection window: You look through the lens into this window before the injection to check that the solution is clear and ready to use.
  • Injection indicator: Before the injection, you can see a white plastic plunger through the window. This means that the ANAPEN® Auto-Injector has not been fired by mistake or tampered with. After the injection, the injection indicator turns red. This indicates that the ANAPEN® Auto-Injector has been fired correctly.
  • Black needle shield (reversible): This protects the needle when you are not using the ANAPEN® Auto-Injector. You pull the needle shield off before the injection. After the injection, turn the black needle shield around and put it back onto the same end of ANAPEN® Auto-Injector, to cover the needle.
  • Grey safety cap: This covers the red firing button. It stops the button from being pushed by mistake.

Do not remove the black needle shield or the grey safety cap until you need to use your ANAPEN® Auto-Injector.

B. Checking your ANAPEN® Auto-Injector

Before you use your ANAPEN® Auto-Injector, and on a regular basis, you must check it as follows:

1. Rotate the cover over the solution window fully anticlockwise as indicated by the arrow to line up the lenses with the solution window on the auto-injector body.

2. Look through the lens into the solution window. Check that the solution is clear and colourless. If it is cloudy, coloured or contains particles, discard the ANAPEN® Auto-Injector.

3. Make sure that the injection indicator is not red. If it is red, this means that the ANAPEN® Auto-Injector has already been fired and you must discard it.

4. Rotate the cover over the solution window fully back clockwise as shown by the arrow, to ensure that the solution window is covered. Put the ANAPEN® Auto-Injector back in the carton until you need to use it.

C. Using the ANAPEN® Auto-Injector

If the black needle shield has been removed, do not put your thumb, fingers or hand over the open end (needle end) of the ANAPEN® Auto-Injector.

To use the ANAPEN® Auto-Injector, follow the steps below:

1. Remove the black needle shield by pulling hard, in the direction of the arrow. This also removes an inner protective needle shield which is housed inside the rigid black needle shield.

2. Remove the grey safety cap from the red firing button, by pulling as indicated by the arrow.

3. Hold the open end (needle end) of ANAPEN®against the outer part of your thigh. If necessary, you can use ANAPEN® through light clothing, such as denim, cotton or polyester.

4. Press the red firing button so that it clicks. Keep holding the ANAPEN® Auto-Injector against your thigh for 3 seconds. Slowly remove ANAPEN® from your thigh.

5. The injection indicator will have turned red. This shows that the injection is complete.

If the injection indicator is not red, you must repeat the injection with a new ANAPEN®.

6. After the injection, the needle sticks out. To cover it, click the wide end of the black needle shield back on the open end (needle end) of ANAPEN® Auto-Injector (as indicated by the arrow).

Help in using ANAPEN®

It is important to know how to use an ANAPEN® BEFORE a severe allergic reaction causes a medical emergency.

Ask your doctor or pharmacist how you can get an ANAPEN® Training Device for practice.

An ANAPEN® Training Device is similar to the real ANAPEN®. However, the ANAPEN® Training Device has

  • NO medicine (adrenaline) and
  • NO needle and
  • “fires” quietly and less forcefully.

Ask your doctor or pharmacist to show you how to practice with the ANAPEN® Training Device. If you practice using the ANAPEN® Training Device, it will help you to learn how to use the real ANAPEN®.

It is important to regularly ask your doctor or pharmacist to demonstrate use with an ANAPEN® Training Device.

Please scan the QR code for access to Instructional video on website

ANAPEN® is effective as emergency treatment of a severe allergic reaction ONLY when used according to the directions in this leaflet.

If you use too much ANAPEN®

Because each ANAPEN® contains only one dose, overdosage is unlikely. Overdosage may lead to a rise in blood pressure. This may cause bleeding in the brain or fluid in the lung.

If you think that you or anyone else may have used too much ANAPEN®, you may need urgent medical attention.

You should immediately:

  • phone the Poisons Information Centre
    (by calling 13 11 26), or
  • contact your doctor, or
  • go to the Emergency Department at your nearest hospital.

You should do this even if there are no signs of discomfort or poisoning.

5. What should I know while using ANAPEN®?

Things you should do

ANAPEN® is designed as emergency treatment. You should always get medical help immediately after using ANAPEN®. Dial 000; ask for an ambulance and state ‘anaphylaxis’ even if symptoms appear to be improving. You will need to go to hospital for observation and further treatment as required. This is because the reaction may happen again at some time later.

While waiting for the ambulance you should lie down with your legs raised unless this makes you breathless in which case you should sit up. Ask someone to stay with you until the ambulance arrives in case you feel unwell again.

Unconscious patients should be placed on their side in the recovery position.

Check what the expiry date is on your ANAPEN®. Mark this expiry date on your calendar or diary. Replace your ANAPEN® prior to this expiry date.

Also note on your calendar or diary to check the contents of your ANAPEN® each month. Do this through the “solution window” - refer to Figure 1.

Make sure the solution is clear, colourless and free of particles. If not, obtain a new ANAPEN® immediately.

If the “injection indicator” (refer to Figure 1) is red this means the ANAPEN® has already been “fired” or used. It cannot be used again. Return it to your doctor or pharmacist for disposal. Obtain a new ANAPEN® immediately.

The ANAPEN® Auto-Injector can be damaged and made unusable if it is mishandled.

ANAPEN® is NOT a toy. Keep it out of reach of children.

Things you should not do

Do not use ANAPEN® to treat any other complaints unless your doctor tells you to.

Do not give your medicine to anyone else, even if they have the same condition as you.

Do not use in children under 15 kg unless advised by your doctor.

Do not use if the solution is cloudy, coloured or contains particles.

Do not inject into hands, feet, ears, nose, buttocks, genital area or into a blood vessel.

If this does happen accidentally you must immediately seek medical attention. See Section 6. Are there any side effects?

Do not inject into the buttock.

Rare cases of serious skin infections have been reported following injection into the buttock. If you develop signs or symptoms of infection, such as persistent redness, warmth, swelling, or tenderness, at the adrenaline injection site you must seek medical attention immediately.

Driving or using machines

You should not drive or use machinery after injecting this medicine, since you may still be experiencing the effects of an anaphylactic shock.

Drinking alcohol

Tell your doctor if you drink alcohol.

Alcohol may adversely affect this medicine by increasing the effects of this medicine.

Looking after your medicine

Storage

Keep ANAPEN® available with the person for whom, it is intended.

Keep ANAPEN® in a cool dry place below 25°C. A temperature range between 15°C to 25°C is acceptable.

Keep the auto-injector in the outer carton in order to protect from light. Do not refrigerate or freeze. Store ANAPEN® lying down.

Do not leave ANAPEN® in your car. Extreme temperatures may cause the auto-injector unit to malfunction.

Do not use this medicine after the expiry date (Exp. Date) which is stated on the carton and the auto-injector. The expiry date refers to the last day of that month.

Discard and replace ANAPEN® after the expiry date. Check the solution regularly through the solution window to make sure the solution is clear, colourless and particle free.

Discard and replace ANAPEN® if the solution is cloudy, coloured or contains particles.

You should inspect your pen regularly as shown in the section on how to use ANAPEN® under the heading Instructions for use. This is to ensure ANAPEN® can be used in an emergency.

Keep it where young children cannot reach it.

When to discard your medicine (as relevant)

Do not dispose of any medicines via wastewater or household waste. Ask your pharmacist how to dispose of any unwanted medicines you no longer use. These measures will help protect the environment.

Give your used ANAPEN® to the hospital or pharmacist for proper disposal

The used ANAPEN® should be placed in a rigid sharps disposal unit.

Getting rid of any unwanted medicine

If you no longer need to use this medicine or it is out of date, take it to any pharmacy for safe disposal.

Do not use this medicine after the expiry date.

6. Are there any side effects?

All medicines can have side effects. If you do experience any side effects, most of them are minor and temporary. However, some side effects may need medical attention.

See the information below and, if you need to, ask your doctor or pharmacist if you have any further questions about side effects.

Less serious side effects

Less serious side effectsWhat to do
Related to heart/chest
  • Fast, uneven or noticeable heart beat
  • difficulty breathing
  • chest pain
  • shortness of breath
Related to nervous system(head)
  • dilated pupils
  • dizziness
  • hallucinations
  • headache
  • throbbing
  • anxiety
  • fear
  • apprehension
  • sleeplessness
  • nervousness
Related to whole body
  • pale skin colour
  • weakness
  • fainting
  • muscle shakes
  • tremor
  • sweating
  • nausea or vomiting
  • coldness
  • restlessness
  • flushing or redness of face and skin
  • reduced blood flow to the skin (mucous tissues and kidneys)
  • coldness of extremities
Related to blood tests
  • Changes to the blood such as high sugar levels, low potassium levels, high acid content
Related to urinary system
  • Difficulty in urinating
Speak to your doctor if you have any of these less serious side effects and they worry you.
These side effects are minor and short lasting.

Serious side effects

Serious side effectsWhat to do
Heart/cardiovascular system
  • Stroke
  • Severe irregular heartbeat and heart attack
  • Raised blood pressure
  • Sudden increase in blood pressure which may cause bleeding into the brain
Nervous system
  • disorientation and impaired memory.
Respiratory system
  • Lung problems
Call your doctor straight away, or go straight to the Emergency Department at your nearest hospital if you notice any of these serious side effects.

Tell your doctor or pharmacist if you notice anything else that may be making you feel unwell.

Accidental injection into the hands, fingers or feet may result in the following:

  • fast or noticeable heart beat
  • pale skin colour at the site of accidental injection
  • feeling of coldness at the site of accidental injection
  • bruising or discolouration at the site of accidental injection
  • bleeding

If an accidental injection occurs at one of these areas, seek medical attention immediately.

Injection related injuries, such as needle cuts and bent needles, have been reported in people who are uncooperative and kick or move during the injection.

Sodium metabisulfite

ANAPEN® contains a very small quantity of sodium metabisulfite. In people who are allergic to sodium metabisulfite, this could cause, for example, severe asthma. However, the active ingredient, adrenaline, in ANAPEN® is expected to overcome any allergic reaction to sodium metabisulfite. In an emergency, the risk of exposure to the very small amount of sodium metabisulfite is generally outweighed by the benefits of ANAPEN®.

Other side effects not listed here may occur in some people.

Reporting side effects

After you have received medical advice for any side effects you experience, you can report side effects to the Therapeutic Goods Administration online at www.tga.gov.au/reporting-problems. By reporting side effects, you can help provide more information on the safety of this medicine.

Always make sure you speak to your doctor or pharmacist before you decide to stop taking any of your medicines.

7. Product details

ANAPEN® may be prescribed by your doctor and is only available through a pharmacist.

What ANAPEN® contains

Active ingredient
(main ingredient)
adrenaline (epinephrine)
Other ingredients
(inactive ingredients)
  • Sodium metabisulfite
  • Sodium Chloride
  • Hydrochloric acid
  • Water for injections
Potential allergensSodium metabisulfite

Do not use this medicine if you are allergic to any of these ingredients.

What ANAPEN® looks like

ANAPEN® consists of a pre-filled syringe* of adrenaline solution for injection contained in an auto injection device (Auto-Injector). One dose of 0.3 mL contains 150/300/500 micrograms of adrenaline (epinephrine). ANAPEN® is a clear colourless solution free from visible particles.

ANAPEN® is supplied in packs of 1 or 2 auto-injectors with a thermoformed tray protection into the carton. Not all pack sizes may be marketed.

*Exposed needle length: 10 mm ± 1.5 mm.

ANAPEN® Junior 150 AUST R 337517

ANAPEN®300 AUST R 337512

ANAPEN®500 AUST R 337516

Who distributes ANAPEN®

ANAPEN® is supplied in Australia by:

Allergy Concepts
Suite 405, Level 4
83 York Street
Sydney NSW 2000
Ph: 1800761964

® = Registered Trademark

This leaflet was prepared in Oct 2022

Published by MIMS January 2023

BRAND INFORMATION

Brand name

Anapen

Active ingredient

Adrenaline (epinephrine)

Schedule

S3

 

1 Name of Medicine

Adrenaline (epinephrine).

2 Qualitative and Quantitative Composition

Anapen Junior 150 micrograms: Each 0.3 mL contains 150 micrograms of adrenaline (epinephrine).
Anapen 300 micrograms: Each 0.3 mL contains 300 micrograms of adrenaline (epinephrine).
Anapen 500 micrograms: Each 0.3 mL contains 500 micrograms of adrenaline (epinephrine).

Excipients with known effect.

Sulfites.
For full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

Solution for injection in a pre-filled syringe (auto-injector). Clear, colourless solution practically free from visible particles.

4 Clinical Particulars

4.1 Therapeutic Indications

For the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, drugs or other allergens.

4.2 Dose and Method of Administration

Product is for single use in one patient only. Discard any residue.
The patient should always carry 2 units of auto injectors in case the first administration fails or if one dose is not sufficient.
The effective dose is typically in the range 5-10 micrograms per kilogram of bodyweight but higher doses may be necessary in some cases.

Use in adults.

The usual dose is 300 micrograms. The recommended dose is 300 micrograms for individuals under 60 kg bodyweight. The recommended dose is 300 to 500 micrograms for individuals over 60 kg bodyweight, depending on clinical judgement.
Larger adults may require more than one injection to reverse the effect of an allergic reaction.
In the absence of clinical improvement or if deterioration occurs, a second injection with an additional Anapen may be administered 5-15 minutes after the first injection. It is recommended that patients are prescribed two Anapen which they should carry at all times.
In case of a second injection needed it is recommended to inject in the opposite thigh.
Patients must be shown how to use the Anapen device at the time a prescription is written.

Use in children.

Anapen 500 micrograms is not recommended for use in children. The appropriate dose may be 150 micrograms (Anapen Junior) or 300 micrograms (Anapen) of adrenaline (epinephrine), depending on the body weight of the child and the discretion of the doctor.
Children and adolescents over 30 kg in weight should be prescribed Anapen 300 micrograms. Larger children may require more than one injection to reverse the effect of an allergic reaction. In the absence of clinical improvement or if deterioration occurs, a second injection with an additional Anapen Junior may be administered 5-15 minutes after the first injection. It is recommended that patients are prescribed two Anapen Junior which they should carry at all times.
The auto-injector of Anapen Junior is designed to deliver a single dose of 150 micrograms adrenaline (epinephrine), a dosage below 150 micrograms cannot be administered in sufficient accuracy in children weighing less than 15 kg and use is therefore not recommended unless in a life-threatening situation and under medical advice.
In the absence of clinical improvement or if deterioration occurs, a second injection with an additional Anapen may be administered 5-15 minutes after the first injection. It is recommended that patients are prescribed two Anapen which they should carry at all times.
In case of a second injection needed it is recommended to inject in the opposite thigh.

Method of administration.

For intramuscular route only.
Anapen consists of a pre-filled syringe of adrenaline (epinephrine) contained in an auto-injection device. The whole is referred to as an auto-injector.
One Anapen injection should be administered intramuscularly immediately on the appearance of the signs and symptoms of anaphylactic shock. These may occur within minutes of exposure to the allergen and are most commonly manifested by urticaria, flushing or angioedema; more severe reactions involve the circulatory and respiratory systems. Inject Anapen only into the anterolateral aspect of the thigh, not the buttock. The auto-injector is designed to inject through clothing or directly through the skin.
Anapen auto-injector is intended for immediate self-administration by a person with a history of anaphylaxis and is designed to deliver a single dose of 150/300/500 micrograms adrenaline (epinephrine). For stability reasons 0.75 mL is left in the syringe after use but the unit cannot be used again and should be safely discarded.
The patient/carer should be informed that following each use of Anapen:
They should call for immediate medical assistance, ask for an ambulance and state 'anaphylaxis' even if symptoms appear to be improving (see Section 4.4 Special Warnings and Precautions for Use).
Conscious patients should preferably lie flat with legs elevated but sit up if they have breathing difficulties. Unconscious patients should be placed on their side in the recovery position.
The patient should if possible remain with another person until medical assistance arrives.

Mechanism of action.

A. Parts of the Anapen Auto-Injector. Before using the Anapen Auto-Injector, the patient needs to know about the parts of the autoinjector. These are shown in Figure 1.

Rotating cover over solution window.

The patient rotates the cover over the solution window to line up the lenses with the solution window on the auto-injector body.

Solution window.

The patient looks through the lens into this window before the injection to check that the solution is clear and ready to use.

Injection indicator.

Before the injection, the patient can see a white plastic plunger through the window. This means that the Anapen Auto-Injector has not been fired by mistake or tampered with. After the injection, the injection indicator turns red. This indicates that the Anapen Auto-Injector has been fired correctly.

Black needle shield (reversible).

This protects the needle when the patient is not using the Anapen Auto-Injector. The patient pulls the needle shield off before the injection. After the injection, the patient turns the black needle shield around and puts it back onto the same end of Anapen Auto-Injector, to cover the needle.

Grey safety cap.

This covers the red firing button. It stops the button from being pushed by mistake.
The patient must not remove the black needle shield or the grey safety cap until they need to use the Anapen Auto-Injector.
B. Checking the Anapen Auto-Injector. Before using the Anapen Auto-Injector, the patient must check it as follows:
1. Rotate the cover over the solution window fully anti-clockwise as shown by the arrow to line up the lenses with the solution window on the auto-injector body.
2. Look through the lens into the solution window. Check that the solution is clear and colourless.
If it is cloudy, coloured or contains particles, discard the Anapen Auto-Injector.
3. Make sure that the injection indicator is not red. If it is red, this means that the Anapen Auto-Injector has already been fired and you must discard it.
4. Rotate the cover over the solution window fully back clockwise as shown by the arrow, to ensure that the solution window is covered. Put the Anapen Auto-Injector back in the carton until you need to use it.
C. Using the Anapen Auto-Injector. If the black needle shield has been removed, the patient must not put their thumb, fingers or hand over the open end (needle end) of the Anapen Auto-Injector.
To use the Anapen Auto-Injector, the patient must follow the steps below:
1. Remove the black needle shield by pulling hard in the direction of the arrow.
This also removes a grey protective needle shield.
2. Remove the grey safety cap from the red firing button by pulling as indicated by the arrow.
3. Hold the open end (needle end) of Anapen against the outer part of the thigh. If necessary, Anapen can be used through light clothing, such as denim, cotton or polyester.
4. Press the red firing button so that it clicks. Keep holding the Anapen Auto-Injector against the outer thigh for 3 seconds. Slowly remove Anapen from the thigh.
5. The injection indicator will have turned red. This shows that the injection is complete. If the injection indicator is not red, injection must be repeated with a new Anapen.
6. After the injection, the needle sticks out. To cover it, click the wide end of the black needle shield back on the open end (needle end) of Anapen Auto-Injector (as indicated by the arrow).
Immediately after using Anapen the patient should call the emergency services, ask for an ambulance and say "anaphylaxis". The patient should explain to the paramedic that he/she has received an injection of adrenaline into his/her thigh muscle and show them the box and these instructions.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements (see Section 6.6 Special Precautions for Disposal).

4.3 Contraindications

Hypersensitivity to adrenaline (epinephrine) or to any of the excipients listed in Section 6.1 List of Excipients (see Section 4.4 Special Warnings and Precautions for Use for further information on sodium metabisulfite). There are no absolute contraindications for use in allergic emergency situations.

4.4 Special Warnings and Precautions for Use

All patients who are prescribed Anapen should be thoroughly instructed to understand the indications for the use and the correct method of administration (see Section 4.2 Dose and Method of Administration). It is strongly advised also to educate the patient's immediate associates (e.g. family members, caregivers, teachers, co-workers) for the correct usage of Anapen in case support is needed in the emergency situation.
Anapen is indicated as emergency supportive therapy only and patients should be advised to seek immediate medical attention following administration, in order to have close monitoring of the anaphylactic episode and further treatment as required.
The patient/carer should be informed about the possibility of biphasic anaphylaxis which is characterised by initial resolution followed by recurrence of symptoms some hours later.
Patients with concomitant asthma may be at increased risk of a severe anaphylactic reaction.
Adrenaline can cause potentially fatal ventricular arrhythmias including fibrillation, especially in patients with organic heart disease or those receiving other drugs that sensitise the heart to arrhythmias.
Adrenaline causes ECG changes including a decrease in T-wave amplitude in all leads of normal persons. Caution should be taken when administering in the presence of cardiac dilatation.
In patients with parkinsonism the drug increases rigidity and tremor.
Use with caution in patients with heart disease e.g coronary heart and cardiac muscle diseases (angina may be induced), cor pulmonale, cardiac arrhythmias or tachycardia. There is a risk of adverse reactions following adrenaline (epinephrine) administration in patients with hyperthyroidism, cardiovascular disease (severe angina pectoris, obstructive cardiomyopathy and ventricular arrhythmia and hypertension), phaeochromocytoma, high intraocular pressure, severe renal impairment, prostatic adenoma leading to residual urine, hypercalcemia, hypokalaemia, diabetes, or in elderly or pregnant patients.
Repeated local injection can result in necrosis at sites of injection from vascular constriction.
Accidental intravascular injection may result in cerebral haemorrhage due to a sudden rise in blood pressure.
Accidental injection into hands or feet may cause loss of blood flow to adjacent areas due to vasoconstriction.
This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially sodium free.
Patients should be warned regarding related allergens and should be investigated whenever possible so that their specific allergens can be characterised.
Anapen contains sodium metabisulfite which can cause allergic-type reactions including anaphylactic symptoms and bronchospasm in susceptible people, especially those with a history of asthma. Patients with these conditions must be carefully instructed in regard to the circumstances under which Anapen should be used.

Use in the elderly.

Use in elderly: use with caution in elderly patients (see Section 4.4 Special Warnings and Precautions for Use).

Paediatric use.

Use in children: Anapen 500 micrograms is not recommended for use in children (see Section 4.2 Dose and Method of Administration).

Effects on laboratory tests.

No data available.

4.5 Interactions with Other Medicines and Other Forms of Interactions

Central nervous system and other medicines.

The effects of adrenaline (epinephrine) may be potentiated by tricyclic antidepressants mixed noradrenargic-serotoninergic antidepressants like venlafaxine, sibutramine or milnacipran and monoamine oxidase inhibitors (sudden blood pressure increase and possible cardiac arrhythmia), COMT blocking agent, thyroid hormones, theophylline, oxytocin, parasympatholytics, certain antihistamines (diphenhydramine, chlorpheniramine), levodopa and alcohol.

Beta-adrenergic blocking agents.

Severe hypertension and bradycardia may occur when adrenaline (epinephrine) is administered with non-selective beta-blocking medicinal products. Anti-anaphylactic effects can be antagonised by beta-blocking agents, especially non-selective beta blockers.

Other sympathomimetic agents.

Concurrent therapy with sympathomimetics may potentiate the effects of adrenaline (epinephrine).

General anaesthetics.

Use Anapen with caution in patients receiving medicinal products which may sensitise the heart to arrhythmias, e.g. digitalis, quinidine, halogenated anaesthetics.

Alpha-adrenergic blocking agents.

The pressor effects of adrenaline (epinephrine) may be counteracted by administration of rapidly acting vasodilators or alpha-adrenergic blocking medicinal products.

Hypoglycaemic agents.

Adrenaline (epinephrine) inhibits insulin secretion and diabetic patients may require upward adjustment of their insulin or other hypoglycaemic therapy.

4.6 Fertility, Pregnancy and Lactation

Effects on fertility.

Studies of adrenaline (epinephrine) after repeated exposure in animals to evaluate the effect of fertility have not been conducted. This should not prevent the use of adrenaline (epinephrine) under the conditions noted under the Therapeutic Indications (see Section 4.1).
(Category A)
Adrenaline has been given to a large number of pregnant woman and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the foetus having been observed.
Adrenaline may delay the second stage of labour by inhibiting contractions of the uterus.
Use with caution in pregnant women whose maternal blood pressure is in excess of 130/80.
Adrenaline is excreted in breast milk.

4.7 Effects on Ability to Drive and Use Machines

It is not recommended that patients should drive or use machines following administration of adrenaline (epinephrine), since patients will be affected by symptoms of the anaphylactic shock.

4.8 Adverse Effects (Undesirable Effects)

The occurrence of undesirable effects depends on the sensitivity of the individual patient and the dose applied.
The following table (see Table 1) is based upon experience with the use of adrenaline.
The adverse events are classified as MedDRA preferred term by system organ class and frequency; frequencies are defined as: very common (≥ 1/10), common (≥ 1/100, < 1/10), uncommon (≥ 1/1,000, < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from the available data).
Anapen contains sodium metabisulfite which may cause allergic-type reactions including anaphylactic reactions, life-threatening or less severe asthmatic episodes in certain susceptible patients.

Reporting suspected adverse effects.

Reporting suspected adverse reactions after registration of the medicinal product is important. It allows continued monitoring of the benefit-risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions at www.tga.gov.au/reporting-problems.

4.9 Overdose

Overdose or accidental intravascular injection of adrenaline (epinephrine) may cause cerebral haemorrhage from a sudden rise of blood pressure. Death may result from acute pulmonary oedema arising from peripheral vascular constriction and cardiac stimulation.
The pressor effects of adrenaline (epinephrine) may be counteracted by rapidly acting vasodilators or alpha-adrenergic blocking medicinal products. Should prolonged hypotension follow such measures, it may be necessary to administer another pressor medicinal product, such as noradrenaline.
Acute pulmonary oedema with respiratory embarrassment following adrenaline (epinephrine) overdose should be managed by administration of a rapidly acting alpha adrenergic blocking medicinal product such as phentolamine and/or with intermittent positive pressure respiration.
Adrenaline (epinephrine) overdose may also result in transient bradycardia followed by tachycardia; these can be followed by potentially fatal cardiac arrhythmias which may be treated by beta adrenergic blocking medicinal products. These must be preceded or accompanied by an alpha-adrenergic blocker to control the alpha-mediated effects on the peripheral circulation.
For information on the management of overdose, contact the Poisons Information Centre on 13 11 26 (Australia).

5 Pharmacological Properties

5.1 Pharmacodynamic Properties

Pharmacotherapeutic group: cardiac stimulants excl. cardiac glycosides, adrenergic and dopaminergic agents, adrenaline (epinephrine).

Mechanism of action.

Adrenaline (epinephrine) is a sympathomimetic drug, acting on both alpha and beta receptors. Through its action on alpha adrenergic receptors, adrenaline lessens the vasodilatation and increased vascular permeability that occurs during anaphylaxis, which can lead to a loss of intravascular fluid volume and hypotension. Through its action on beta-adrenergic receptors, adrenaline causes bronchial smooth muscle relaxation that helps alleviate bronchospasm, wheezing and dyspnoea that may occur during anaphylaxis. Other major effects are increased systolic blood pressure, reduced diastolic pressure, tachycardia, hyperglycaemia and hypokalaemia. It is a powerful cardiac stimulant. It has vasopressor properties, an antihistaminic action and is a bronchodilator. Adrenaline also alleviates pruritus, urticaria, and angioedema and may be effective in relieving gastrointestinal and genitourinary symptoms associated with anaphylaxis because of its relaxant effects on the smooth muscle of the stomach, intestine, uterus, and urinary bladder.

Clinical trials.

No data available.

5.2 Pharmacokinetic Properties

Adrenaline (epinephrine) is rapidly inactivated in the body, mostly in the liver by the enzymes COMT and MAO. Much of a dose of adrenaline (epinephrine) is excreted as metabolites in urine. The plasma half-life is about 2-3 minutes. However, when given by subcutaneous or intramuscular injection, local vasoconstriction may delay absorption so that the effects may last longer than the half-life suggests.

Study P14-04.

This randomized, open-label, cross-over study compared the impact of adrenaline administration at two sites in the thigh of 18 normal weight male volunteers, using either Anapen or the prefilled syringe; in addition, it was also studied the treatment of 12 overweight women with Anapen. The depot depth was measured by ultrasonography, plasma adrenaline was evaluated by UPLC-mass spectrometry, and heart rates (HR) were measured using a Holter monitor.
Adrenaline levels showed a double peak, with parallel changes in HR. The first peak, of potential vital importance in anaphylaxis treatment, occurred at approximately 10 min post-injection, with Cmax and AUC significantly higher with Anapen than with pre-filled syringes; the magnitude of the second peak did not differ among the various conditions. In overweight women treated with Anapen administered at inferior anterior third of the thigh, the magnitude of the first peak was similar to that observed in men, despite the injection being subcutaneous and the overall bioavailability was enhanced.
The results (mean values) of the main pharmacokinetic parameters are presented in Table 2.
The adrenaline pharmacokinetics and cardiovascular responses in both sets of data were well correlated both in the time-course and relative amplitude. In particular, the changes in adrenaline plasma levels and heart rate (HR) clearly showed two successive peaks (see Figure 2). The first peak occurred a few minutes after the injection (Cmax1 and Emax at approximately 10 min post-administration), lasted less than 20 min, and was followed by a larger peak, generally of similar height, which lasted up to 2 h.

5.3 Preclinical Safety Data

Adrenaline (epinephrine) has been widely used in the clinical management of allergic emergencies for many years. There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the PI.

Genotoxicity.

Adrenaline and other catecholamines have been shown to have mutagenic potential in vitro and to be an oxidative mutagen in a WP2 bacterial reverse mutation assay. Adrenaline had a moderate degree of mutagenicity and was positive in the DNA repair test with B. subtilis (REC) assay but was not mutagenic in the Salmonella bacterial reverse mutation assay.
Studies of adrenaline after repeated exposure in animals to evaluate the carcinogenic potential have not been conducted. This should not prevent the use of adrenaline under the conditions noted, see Section 4.1 Therapeutic Indications.

Carcinogenicity.

Carcinogenicity studies have not been conducted with Anapen.

6 Pharmaceutical Particulars

6.1 List of Excipients

Sodium chloride, sodium metabisulfite, hydrochloric acid (for adjustment of pH), water for injections.

6.2 Incompatibilities

In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.

6.3 Shelf Life

Anapen Junior 150 micrograms.

21 months.

Anapen 300 micrograms, Anapen 500 micrograms.

2 years.
In Australia, information on the shelf life can be found on the public summary of the Australian Register of Therapeutic Goods (ARTG). The expiry date can be found on the packaging.

6.4 Special Precautions for Storage

Store below 25°C.
Keep the auto-injector in the outer carton in order to protect from light. Do not refrigerate or freeze.
Anapen should be stored lying down.
See Section 4.2 Dose and Method of Administration for instructions to be conveyed to the patient/ carer regarding actions to be taken following each use of Anapen.
It is very important that the patient receives detailed information on how to use Anapen.
For single use only.
The expiry date is indicated on the label and Anapen should not be used after this date.
Discard and replace the auto-injector after expiry date.
The solution should be examined regularly through the inspection window. Discard and replace Anapen if the solution is cloudy, coloured or contains particles.
The integral medicinal product, as shown (see Section 4.2 Dose and Method of Administration), should be regularly checked to ensure that it is ready to use in an emergency situation.

6.5 Nature and Contents of Container

Anapen consists of a pre-filled syringe contained in a single use auto-injection device.
The syringe contains adrenaline (epinephrine) solution. The auto-injection device delivers this solution.
The immediate container is a glass syringe sealed by a rubber plunger at one end, and at the other end by a rubber needle shield.

Syringe.

BD (Becton Dickinson) borosilicate glass type 1, 27G 1/2".
Exposed needle length: 10 mm ± 1.5 mm.

Plunger.

BD (Becton Dickinson) black chlorobutyl rubber PH 701/50.
In pack sizes of 1 or 2 with a thermoformed tray protection inside a cardboard box. Not all pack sizes may be marketed.

6.6 Special Precautions for Disposal

In Australia, any unused medicine or waste material should be disposed of by taking to your local pharmacy.

6.7 Physicochemical Properties

Clear colourless solution practically free from particles.

Anapen Junior 150 micrograms.

Each 0.3 mL dose contains 150 micrograms of adrenaline (epinephrine).

Anapen 300 micrograms.

Each 0.3 mL dose contains 300 micrograms of adrenaline (epinephrine).

Anapen 500 micrograms.

Each 0.3 mL dose contains 500 micrograms of adrenaline (epinephrine).

Chemical structure.


CAS number.

51-43-4.

7 Medicine Schedule (Poisons Standard)

S3 (Pharmacist Only Medicine).

Summary Table of Changes